Literature DB >> 20145025

Awake seizures after pure sleep-related epilepsy: a systematic review and implications for driving law.

R H Thomas1, W H King, J A Johnston, P E M Smith.   

Abstract

Who with sleep seizures is safe to drive? Driving law is controversial; ineligibility varies between individual US states and EU countries. Current UK driving law is strongly influenced by a single-centre study from 1974 where most participants were not taking antiepileptic drugs (AEDs). However, pure sleep-related epilepsy is often fully controlled on medication, and its withdrawal can provoke awake seizures. This systematic review asked, 'What is the risk of awake seizures in pure sleep-related epilepsy?' 9885 titles were identified; 2312 were excluded (not human or adult); 40 full texts were reviewed; six papers met our inclusion criteria; each of these six studies had a different pure sleep-related epilepsy definition. Using the largest prospective study, we were able to calculate next year's awake seizure chance (treated with antiepileptic medication). This was maximal in the second year: 5.7% (95% CI 3.0 to 10.4%). European licensing bodies including the UK's Driver and Vehicle Licensing Agency broadly accept a risk of less than 20% for Group 1 licensing. However, this study excluded patients with frontal-lobe epilepsies. Furthermore, follow-up (n=160) varied from 2 to 6 years, yet new awake seizures may occur even after 10-20 years of pure sleep-related epilepsy A paucity of evidence underpins present licensing law; current rulings would be difficult to defend if legally challenged. The law may be penalising people with pure sleep-related epilepsy without increased risk of awake seizures, while failing to identify subgroups at unacceptable risk of an awake seizure at the wheel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20145025     DOI: 10.1136/jnnp.2009.181438

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  7 in total

Review 1.  Nocturnal frontal lobe epilepsy.

Authors:  Lino Nobili; Paola Proserpio; Romina Combi; Federica Provini; Giuseppe Plazzi; Francesca Bisulli; Laura Tassi; Paolo Tinuper
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 2.  Sleep and Epilepsy: a Focused Review of Pathophysiology, Clinical Syndromes, Co-morbidities, and Therapy.

Authors:  J Layne Moore; Diego Z Carvalho; Erik K St Louis; Carl Bazil
Journal:  Neurotherapeutics       Date:  2021-03-30       Impact factor: 7.620

Review 3.  Cycles in epilepsy.

Authors:  Philippa J Karoly; Vikram R Rao; Maxime O Baud; Nicholas M Gregg; Gregory A Worrell; Christophe Bernard; Mark J Cook
Journal:  Nat Rev Neurol       Date:  2021-03-15       Impact factor: 42.937

4.  Measuring the effects of sleep on epileptogenicity with multifrequency entropy.

Authors:  Aarti Sathyanarayana; Rima El Atrache; Michele Jackson; Aliza S Alter; Kenneth D Mandl; Tobias Loddenkemper; William J Bosl
Journal:  Clin Neurophysiol       Date:  2021-06-11       Impact factor: 4.861

Review 5.  Consensus guideline for the assessment of fitness for private driving of persons with epilepsy in Korea.

Authors:  Sang-Ahm Lee
Journal:  J Epilepsy Res       Date:  2011-03-30

Review 6.  Sleep-related hypermotor epilepsy: prevalence, impact and management strategies.

Authors:  Veronica Menghi; Francesca Bisulli; Paolo Tinuper; Lino Nobili
Journal:  Nat Sci Sleep       Date:  2018-10-10

7.  Driving a motor vehicle and psychogenic nonepileptic seizures: ILAE Report by the Task Force on Psychogenic Nonepileptic Seizures.

Authors:  Ali A Asadi-Pooya; Timothy R Nicholson; Susannah Pick; Gaston Baslet; Selim R Benbadis; Massimiliano Beghi; Francesco Brigo; Jeffrey Buchhalter; Luciana D'Alessio; Barbara Dworetzky; David Gigineishvili; Richard A Kanaan; Kasia Kozlowska; W Curt LaFrance; Alexander Lehn; David L Perez; Stoyan Popkirov; Chrisma Pretorius; Jerzy P Szaflarski; Benjamin Tolchin; Kette Valente; Jon Stone; Markus Reuber
Journal:  Epilepsia Open       Date:  2020-06-09
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.